Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling Pathways

Arteriosclerosis, Thrombosis, and Vascular Biology - Tập 22 Số 12 - Trang 1990-1995 - 2002
Nathalie Augé1, Virginie Garcia1, Françoise Maupas‐Schwalm1, Thierry Levade1, Robert Salvayre1, Anne Nègre‐Salvayre1
1From INSERM U-466, Université Paul Sabatier, Toulouse, France.

Tóm tắt

Objective— Oxidized low-density lipoprotein (oxLDL)-induced smooth muscle cell (SMC) proliferation requires the coactivation of various signaling pathways, namely sphingomyelin/ceramide/sphingosine-1-phosphate, epithelial growth factor receptor (EGFR), and phosphoinositide 3-kinase (PI-3K) pathways. This study aimed to clarify the respective role and the hypothetical cross-talk between sphingomyelin/ceramide/sphingosine-1-phosphate, EGFR, and PI-3K/Akt pathways in the balance between mitogenic and cytotoxic effects elicited by oxLDL. Methods and Results— Coimmunoprecipitation experiments and the use of inhibitors and dominant-negative mutant showed that oxLDL-induced PI-3K activation is dependent on EGFR. PI-3K activation is independent of the sphingomyelin/ceramide/sphingosine-1-phosphate pathway, because PI-3K inhibition by LY294002 or dominant-negative Δp85 mutant does not abrogate sphingomyelin hydrolysis, and, conversely, the use of permeant C2-ceramide and of N,N -dimethyl-sphingosine, a sphingosine kinase inhibitor, does not alter PI-3K activity. Activation of Akt/PKB by oxLDL requires PI-3K, as shown by the inhibition by LY204002 and in Δp85 SMC. The inhibition of Akt/PKB by PI-3K inhibitor LY204002 or by overexpression of kinase-dead Akt shifted the mitogenic effect of oxLDL toward apoptosis, thus suggesting that the PI-3K/Akt pathway acts as a survival pathway. Conclusions— SMC proliferation elicited by moderate concentrations of oxLDL involves the sphingomyelin/ceramide/sphingosine-1-phosphate pathway, which leads to extracellular regulated kinase 1/2 activation and DNA synthesis, and the EGFR/PI-3K/Akt pathway, which prevents the apoptotic effect of oxLDL.

Từ khóa


Tài liệu tham khảo

10.1038/35025203

10.1038/362801a0

10.1074/jbc.273.21.12893

10.1074/jbc.275.8.5810

10.1074/jbc.273.9.4915

10.1016/S0891-5849(00)00227-6

10.1006/bbrc.1996.0907

10.1093/glycob/6.3.303

10.1096/fasebj.12.9.665

10.1128/MCB.17.3.1595

10.1002/(SICI)1097-0045(20000101)42:1<1::AID-PROS1>3.0.CO;2-Y

10.1074/jbc.M001237200

2001, J Cell Sci, 114, 1439, 10.1242/jcs.114.8.1439

1999, Am J Physiol, 276, G853

1998, Am J Physiol, 275, G705

10.1101/gad.12.13.1941

10.1074/jbc.275.13.9628

10.1073/pnas.91.16.7415

10.1038/378785a0

1986, J Immunol Methods, 89, 371

10.1096/fasebj.13.3.485

10.1074/jbc.273.26.16568

1994, Cell Growth Differ, 5, 341

10.1074/jbc.274.31.21533

10.1038/sj.bjp.0703976

10.1016/S0014-5793(97)00617-0

10.1038/sj.bjp.0703981

10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.0.CO;2-A

10.1074/jbc.273.42.27389

10.1096/fasebj.10.12.8903509

10.1074/jbc.272.16.10777

10.1042/bj3380643

10.1042/bj3360241

10.1074/jbc.275.19.14624

10.1074/jbc.274.32.22699

10.1091/mbc.12.5.1519

2001, J Lipid Res, 42, 1483, 10.1016/S0022-2275(20)30282-0

10.1016/S0014-5793(01)02272-4

10.1016/S0968-0004(01)01958-2

10.1042/bj3091015

2001, Kidney Int, 78, S120

Thông tin
Thông tin xuất bản

Arteriosclerosis, Thrombosis, and Vascular Biology

Tập 22 Số 12

1990-1995

Thông tin tác giả